Xeber.world
Eli Lilly has agreed to acquire Kelonia Therapeutics, a cancer and autoimmune cell therapy startup, for $3.2 billion with potential milestone payments...
Kelonia Therapeutics, a CAR-T biotech on the brink of collapse three times, was acquired by Eli Lilly for $3.25 billion. The deal highlights the secto...
Kelonia Therapeutics transformed from a struggling biotech startup into a $3 billion company. Discover how BioAge’s inflammation-focused strategy and...